Rhumbline Advisers trimmed its stake in shares of Safeguard Scientifics, Inc. (NYSE:SFE) by 0.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,111 shares of the asset manager’s stock after selling 150 shares during the period. Rhumbline Advisers owned 0.12% of Safeguard Scientifics worth $299,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of SFE. Wellington Shields Capital Management LLC lifted its holdings in Safeguard Scientifics by 35.3% during the second quarter. Wellington Shields Capital Management LLC now owns 85,428 shares of the asset manager’s stock valued at $1,017,000 after purchasing an additional 22,300 shares in the last quarter. Citadel Advisors LLC purchased a new position in Safeguard Scientifics during the first quarter valued at $260,000. Pennsylvania Trust Co purchased a new position in Safeguard Scientifics during the second quarter valued at $219,000. Prudential Financial Inc. purchased a new position in Safeguard Scientifics during the first quarter valued at $216,000. Finally, Vanguard Group Inc. lifted its holdings in Safeguard Scientifics by 1.9% during the first quarter. Vanguard Group Inc. now owns 828,897 shares of the asset manager’s stock valued at $10,528,000 after purchasing an additional 15,086 shares in the last quarter. 77.59% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: This news story was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.com-unik.info/2017/10/11/safeguard-scientifics-inc-sfe-holdings-cut-by-rhumbline-advisers.html.
Several research firms have issued reports on SFE. Zacks Investment Research raised shares of Safeguard Scientifics from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 18th. BidaskClub downgraded shares of Safeguard Scientifics from a “buy” rating to a “hold” rating in a report on Tuesday, July 25th. Finally, ValuEngine downgraded shares of Safeguard Scientifics from a “sell” rating to a “strong sell” rating in a report on Monday, August 7th.
Safeguard Scientifics, Inc. (NYSE:SFE) opened at 13.60 on Wednesday. The firm’s 50-day moving average is $12.81 and its 200 day moving average is $12.14. Safeguard Scientifics, Inc. has a 12-month low of $10.60 and a 12-month high of $14.10. The stock’s market capitalization is $277.62 million.
Safeguard Scientifics (NYSE:SFE) last issued its quarterly earnings data on Thursday, July 27th. The asset manager reported ($1.43) EPS for the quarter, missing the Zacks’ consensus estimate of ($1.11) by ($0.32). During the same quarter in the previous year, the business earned $1.92 EPS. Equities analysts expect that Safeguard Scientifics, Inc. will post ($3.49) EPS for the current year.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.
Want to see what other hedge funds are holding SFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Safeguard Scientifics, Inc. (NYSE:SFE).
What are top analysts saying about Safeguard Scientifics Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Safeguard Scientifics Inc. and related companies.